12/17
07:58 am
gh
Rating for GH
Low
Report
Rating for GH
12/17
07:58 am
gh
Rating for GH
Low
Report
Rating for GH
12/15
03:59 pm
gh
Rating for GH
Low
Report
Rating for GH
12/15
03:59 pm
gh
Rating for GH
Low
Report
Rating for GH
12/15
03:46 pm
gh
Rating for GH
Low
Report
Rating for GH
12/15
02:07 pm
gh
Rating for GH
Low
Report
Rating for GH
12/15
01:19 pm
gh
Rating for GH
Low
Report
Rating for GH
12/15
01:19 pm
gh
Rating for GH
Low
Report
Rating for GH
12/15
07:20 am
gh
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
12/15
06:04 am
gh
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/12
06:09 am
gh
Rating for GH
Low
Report
Rating for GH
12/11
04:07 pm
gh
Rating for GH
Low
Report
Rating for GH
12/11
04:07 pm
gh
Rating for GH
Low
Report
Rating for GH
12/11
07:20 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
12/2
12:39 pm
gh
Rating for GH
Low
Report
Rating for GH
12/2
12:39 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
03:14 pm
gh
Rating for GH
Medium
Report
Rating for GH
10/30
02:16 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
02:16 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
12:47 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
12:16 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
12:16 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
10:59 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
10/30
10:07 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
10/30
09:34 am
gh
Rating for GH
Low
Report
Rating for GH